JP2024544538A5 - - Google Patents
Info
- Publication number
- JP2024544538A5 JP2024544538A5 JP2024527603A JP2024527603A JP2024544538A5 JP 2024544538 A5 JP2024544538 A5 JP 2024544538A5 JP 2024527603 A JP2024527603 A JP 2024527603A JP 2024527603 A JP2024527603 A JP 2024527603A JP 2024544538 A5 JP2024544538 A5 JP 2024544538A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- composition according
- approximately
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/130083 | 2021-11-11 | ||
| CN2021130083 | 2021-11-11 | ||
| CN2022097426 | 2022-06-07 | ||
| CNPCT/CN2022/097426 | 2022-06-07 | ||
| PCT/CN2022/131297 WO2023083288A1 (en) | 2021-11-11 | 2022-11-11 | TREATMENT OF LIVER DISORDERS WITH A THR-β AGONIST |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544538A JP2024544538A (ja) | 2024-12-03 |
| JP2024544538A5 true JP2024544538A5 (https=) | 2025-11-18 |
Family
ID=86335128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527603A Pending JP2024544538A (ja) | 2021-11-11 | 2022-11-11 | ＴＨＲ－βアゴニストによる肝障害の治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240293416A1 (https=) |
| EP (1) | EP4429666A4 (https=) |
| JP (1) | JP2024544538A (https=) |
| KR (1) | KR20240101642A (https=) |
| CN (1) | CN118871113A (https=) |
| AU (1) | AU2022388507A1 (https=) |
| CA (1) | CA3238108A1 (https=) |
| CL (1) | CL2024001399A1 (https=) |
| CO (1) | CO2024007225A2 (https=) |
| IL (1) | IL312637A (https=) |
| MX (1) | MX2024005647A (https=) |
| PE (1) | PE20241327A1 (https=) |
| TW (1) | TW202332447A (https=) |
| WO (1) | WO2023083288A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| AU2020336272A1 (en) | 2019-08-23 | 2022-04-14 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2021050945A1 (en) | 2019-09-12 | 2021-03-18 | Terns, Inc. | Thyroid hormone receptor beta agonist compounds |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
| WO2025245216A1 (en) * | 2024-05-22 | 2025-11-27 | Terns Pharmaceuticals, Inc. | Treatment of liver disorders with a thr-beta agonist |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018075650A1 (en) * | 2016-10-18 | 2018-04-26 | Madrigal Pharmaceuticals, Inc. | Methods of treating liver disorders or lipid disorders with a thr-beta agonist |
| AR115666A1 (es) * | 2018-07-02 | 2021-02-10 | Madrigal Pharmaceuticals Inc | Formas sólidas de 2-(3,5-dicloro-4-((5-isopropil-6-oxo-1,6-dihidropiridazin-3-il)oxi)fenil)-3,5-dioxo-2,3,4,5-tetrahidro-1,2,4-triazin-6-carbonitrilo |
| CN111320609A (zh) * | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| WO2020228577A1 (zh) * | 2019-05-10 | 2020-11-19 | 深圳微芯生物科技股份有限公司 | 一种哒嗪酮衍生物及其应用 |
| TW202128668A (zh) * | 2019-12-16 | 2021-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 并環類衍生物、其製備方法及其在醫藥上的應用 |
| US20210379043A1 (en) * | 2020-05-13 | 2021-12-09 | Terns Pharmaceuticals, Inc. | Combination treatment of liver disorders |
| CN114437034A (zh) * | 2020-11-06 | 2022-05-06 | 深圳微芯生物科技股份有限公司 | 一种酞嗪类化合物的可药用盐、晶型及其制备方法 |
-
2022
- 2022-11-11 PE PE2024001030A patent/PE20241327A1/es unknown
- 2022-11-11 AU AU2022388507A patent/AU2022388507A1/en active Pending
- 2022-11-11 CA CA3238108A patent/CA3238108A1/en active Pending
- 2022-11-11 KR KR1020247018844A patent/KR20240101642A/ko active Pending
- 2022-11-11 WO PCT/CN2022/131297 patent/WO2023083288A1/en not_active Ceased
- 2022-11-11 EP EP22892081.5A patent/EP4429666A4/en active Pending
- 2022-11-11 MX MX2024005647A patent/MX2024005647A/es unknown
- 2022-11-11 TW TW111143222A patent/TW202332447A/zh unknown
- 2022-11-11 CN CN202280087379.7A patent/CN118871113A/zh active Pending
- 2022-11-11 IL IL312637A patent/IL312637A/en unknown
- 2022-11-11 JP JP2024527603A patent/JP2024544538A/ja active Pending
-
2024
- 2024-05-01 US US18/651,843 patent/US20240293416A1/en active Pending
- 2024-05-09 CL CL2024001399A patent/CL2024001399A1/es unknown
- 2024-06-07 CO CONC2024/0007225A patent/CO2024007225A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024544538A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2019515884A5 (https=) | ||
| EP2429986B1 (en) | Haloalkyl heteroaryl benzamide compounds | |
| JP2024071370A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP2009102342A5 (https=) | ||
| JP2023504415A5 (https=) | ||
| JP2003509349A5 (https=) | ||
| JP2017513824A5 (https=) | ||
| RU2004132856A (ru) | Фармацевтический препарат с модифицированным высвобождением | |
| JP2015521617A5 (https=) | ||
| JP2024531188A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JP2009513713A5 (https=) | ||
| JP2020510085A5 (https=) | ||
| JP2023500060A5 (https=) | ||
| JP2022527401A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| JP2022503733A5 (https=) | ||
| BRPI0716214A2 (pt) | Composições farmacêuticas para o tratamento de infecções fúngicas. | |
| GB2605894A (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-quinoline-3-carboxamide potassium salt | |
| JP2022520410A5 (https=) |